{"nct_id":"NCT03298412","title":"Effect of Blinatumomab on Minimal Residual Disease (MRD) in Diffuse Large B-Cell Lymphoma (DLBCL) Subjects Post Autologous Hematopoietic Stem Cell Transplantation (aHSCT)","status":"TERMINATED","status_verified_date":"2020-09","start_date":"2018-05-23","start_date_type":"ACTUAL","primary_completion_date":"2019-09-30","primary_completion_date_type":"ACTUAL","completion_date":"2019-09-30","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["AMGN"]}